Vincent Miles
BACK
Partner

Location: Boston, USA
Expertise: Venture Capital

Vincent has more than 30 years of management experience in the biotechnology industry. He identifies and invests in new businesses and supports portfolio companies. Vincent is on the boards of Hydra Biosciences, IFM Therapeutics and Personalis, and has also served on the boards of Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Magellan Diagnostics and PrimeraDx. Before joining Abingworth he was Senior Vice President, Business Development, of Alnylam Pharmaceuticals (a former Abingworth portfolio company).

Previously, Vincent was at Millennium Pharmaceuticals  where he held VP positions in business development, strategic planning and corporate communications. Earlier, he was Director of the technology transfer office at the Dana-Farber Cancer Institute and held VP positions in business development and R&D at RiboGene and Pharmacia. He began his career in R&D at Amersham International. He has a BSc in Biochemistry and a PhD in Molecular Biology from University College London.

 

Administrative Support

Mary-Ellen Craig
Tel: + 781 466 8800
mary-ellen@abingworth.com

Copyright Abingworth 2017

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Vincent Miles
Partner

Location: Boston, USA
Expertise: Venture Capital

Vincent has more than 30 years of management experience in the biotechnology industry. He identifies and invests in new businesses and supports portfolio companies. Vincent is on the boards of Hydra Biosciences, IFM Therapeutics and Personalis, and has also served on the boards of Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Magellan Diagnostics and PrimeraDx. Before joining Abingworth he was Senior Vice President, Business Development, of Alnylam Pharmaceuticals (a former Abingworth portfolio company).

Previously, Vincent was at Millennium Pharmaceuticals  where he held VP positions in business development, strategic planning and corporate communications. Earlier, he was Director of the technology transfer office at the Dana-Farber Cancer Institute and held VP positions in business development and R&D at RiboGene and Pharmacia. He began his career in R&D at Amersham International. He has a BSc in Biochemistry and a PhD in Molecular Biology from University College London.

 

Administrative Support

Mary-Ellen Craig
Tel: + 781 466 8800
mary-ellen@abingworth.com

 
Copyright Abingworth 2017